The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Counterregulatory Actions of Angiotensin-(1-7)
Abstract
Abstract Angiotensin (Ang)-(1-7) is a bioactive component of the renin-angiotensin system that is formed endogenously from either Ang I or Ang II. The first actions described for Ang-(1-7) indicated that the peptide mimicked some of the effects of Ang II, including the release of prostanoids and vasopressin. However, Ang-(1-7) is devoid of vasoconstrictor, central pressor, or thirst-stimulating actions. In fact, new findings reveal depressor, vasodilator, and antihypertensive actions that may be more apparent in hypertensive animals or humans. Thus, the accumulating evidence suggests that Ang-(1-7) may oppose the actions of Ang II either directly or by stimulation of prostaglandins and nitric oxide. These observations are significant because they may explain the effective antihypertensive action of converting enzyme inhibitors in a variety of non–renin-dependent models of experimental and genetic hypertension as well as most forms of human hypertension. In this context, studies in humans and animals showed that the antihypertensive action of converting enzyme inhibitors correlated with increases in plasma levels of Ang-(1-7). In this review, we summarize our knowledge of the mechanisms accounting for the counterregulatory actions of Ang-(1-7) and elaborate on the emerging concept that Ang-(1-7) functions as an antihypertensive peptide within the cascade of the renin-angiotensin system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide
Brosnihan, K. B., Li, P., & Ferrario, C. M. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.523 · Cited by 404
Self-citationEffects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Campbell, D. J., Kladis, A., & Duncan, A. M. (1994) · Hypertension · doi:10.1161/01.hyp.23.4.439 · Cited by 317
Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth
Freeman, E. J., Chisolm, G. M., Ferrario, C. M., & Tallant, E. A. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.104 · Cited by 295
Self-citationSchiavone, M. T., Santos, R. A., Brosnihan, K. B., Khosla, M. C., & Ferrario, C. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4095 · Cited by 288
Self-citationSantos, R. A. S., Campagnole-Santos, M. J., Baracho, N. C. V., Fontes, M. A. P., Silva, L. C. S., Neves, L. A. A., R. Oliveira, D., Caligiorne, S. M., Rodrigues, A. R. V., Gropen, C., et al. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90104-x · Cited by 286
Angiotensin actions in the kidney: Renewed insight into the old hormone
Ichikawa, I., & Harris, R. C. (1991) · Kidney International · doi:10.1038/ki.1991.249 · Cited by 284
Discovery of a distinct binding site for angiotensin II (3–8), a putative angiotensin IV receptor
Swanson, G. N., Hanesworth, J. M., Sardinia, M. F., Coleman, J. K. M., Wright, J. W., Hall, K. L., Miller-Wing, A. V., Stobb, J. W., Cook, V. I., Harding, E. C., et al. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90527-2 · Cited by 268
Welches, W. R., Bridget Brosnihan, K., & Ferrario, C. M. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90108-f · Cited by 254
Self-citationLi, P., Chappell, M. C., Ferrario, C. M., & Brosnihan, K. B. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.394 · Cited by 246
Self-citationDifferential regulation of angiotensin peptide levels in plasma and kidney of the rat.
Campbell, D. J., Lawrence, A. C., Towrie, A., Kladis, A., & Valentijn, A. J. (1991) · Hypertension · doi:10.1161/01.hyp.18.6.763 · Cited by 242
Cited by
Ferrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
Self-citationHydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Touyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
RICE, G. I., THOMAS, D. A., GRANT, P. J., TURNER, A. J., & HOOPER, N. M. (2004) · Biochemical Journal · doi:10.1042/bj20040634 · Cited by 619
Ishiyama, Y., Gallagher, P. E., Averill, D. B., Tallant, E. A., Brosnihan, K. B., & Ferrario, C. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000124667.34652.1a · Cited by 564
Self-citationACE2: from vasopeptidase to SARS virus receptor
Turner, A. J., Hiscox, J. A., & Hooper, N. M. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.04.001 · Cited by 517
Age-Related Morbidity and Mortality among Patients with COVID-19
Kang, S.-J., & Jung, S. I. (2020) · Infection & Chemotherapy · doi:10.3947/ic.2020.52.2.154 · Cited by 515
Devaux, C. A., Rolain, J.-M., & Raoult, D. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.04.015 · Cited by 476
Danser, A. H. J., Epstein, M., & Batlle, D. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15082 · Cited by 457
Li, X. C., Zhang, J., & Zhuo, J. L. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.06.005 · Cited by 435
Myocardial infarction increases ACE2 expression in rat and humans
Burrell, L. M., Risvanis, J., Kubota, E., Dean, R. G., MacDonald, P. S., Lu, S., Tikellis, C., Grant, S. L., Lew, R. A., Smith, A. I., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi114 · Cited by 423
Renin angiotensin system and gender differences in the cardiovascular system
Fischer, M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00479-5 · Cited by 384
Ferrario, C. M., Trask, A. J., & Jessup, J. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00618.2005 · Cited by 385
Self-citationSantos, R. A. S., Campagnole-Santos, M. J., & Andrade, S. P. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00138-5 · Cited by 380
ACE2, a new regulator of the renin–angiotensin system
Burrell, L. M., Johnston, C. I., Tikellis, C., & Cooper, M. E. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.03.001 · Cited by 362
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
Paizis, G., Tikellis, C., Cooper, M. E., Schembri, J. M., Lew, R. A., Smith, A. I., Shaw, T., Warner, F. J., Zuilli, A., Burrell, L. M., et al. (2005) · Gut · doi:10.1136/gut.2004.062398 · Cited by 334
Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptor
Tallant, E. A., Ferrario, C. M., & Gallagher, P. E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00941.2004 · Cited by 318
Self-citationZisman, L. S., Keller, R. S., Weaver, B., Lin, Q., Speth, R., Bristow, M. R., & Canver, C. C. (2003) · Circulation · doi:10.1161/01.cir.0000094734.67990.99 · Cited by 308
Iwai, M., & Horiuchi, M. (2009) · Hypertension Research · doi:10.1038/hr.2009.74 · Cited by 296
The renin-angiotensin system and malignancy
Ager, E. I., Neo, J., & Christophi, C. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn171 · Cited by 295
Bader, M., Peters, J., Baltatu, O., Müller, D. N., Luft, F. C., & Ganten, D. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100210 · Cited by 279
Angiotensin receptors: distribution, signalling and function
DINH, D. T., FRAUMAN, A. G., JOHNSTON, C. I., & FABIANI, M. E. (2001) · Clinical Science · doi:10.1042/cs1000481 · Cited by 268
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes
Giacchetti, G., Sechi, L. A., Rilli, S., & Carey, R. M. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.02.003 · Cited by 267
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide
Berry, C., Touyz, R., Dominiczak, A. F., Webb, R. C., & Johns, D. G. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.6.h2337 · Cited by 259
Ferrario, C. M., Jessup, J., Gallagher, P. E., Averill, D. B., Brosnihan, K. B., Ann Tallant, E., Smith, R. D., & Chappell, M. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00675.x · Cited by 259
Self-citationDistribution of Angiotensin-(1-7) and ACE2 in Human Placentas of Normal and Pathological Pregnancies
Valdés, G., Neves, L. A. A., Anton, L., Corthorn, J., Chacón, C., Germain, A. M., Merrill, D. C., Ferrario, C. M., Sarao, R., Penninger, J., et al. (2006) · Placenta · doi:10.1016/j.placenta.2005.02.015 · Cited by 256
Self-citationBrosnihan, K. B., Li, P., Ganten, D., & Ferrario, C. M. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.273.6.r1908 · Cited by 156
Self-citationThe Ovarian Renin-Angiotensin System (OVRAS): A Major Factor in Ovarian Function and Disease
Palumbo, A., Ávila, J., & Naftolin, F. (2016) · Reproductive Sciences · doi:10.1177/1933719116672588 · Cited by 65
Devaux, C. A., & Camoin-Jau, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1042200 · Cited by 20
Metadata
- Authors
- Ferrario, C. M., Chappell, M. C., Tallant, E. A., Brosnihan, K. B., & Diz, D. I.
- Venue
- Hypertension
- Published
- 1997-09
- Volume
- 30
- Issue
- 3
- Pages
- 535-541
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W1970068637
- Cited by
- 509
- References
- 45
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.